Clinical Study on the Safety and Efficacy of a New Magnetic Navigation Radiofrequency Ablation Catheter for Rapid Arrhythmia

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2028

Conditions
Rapid ArrhythmiaPFASymptomatic Supraventricular Tachycardia
Interventions
DEVICE

FireMagic™ Magbot Ablation Catheter

All patients signed informed consent forms, enrolled in the trial, underwent surgical treatment for rapid arrhythmia using XX, and were discharged after follow-up data collection. The total duration for each subject is estimated to be approximately 7 days.

Trial Locations (1)

200025

Ruijin Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors
lead

Shanghai MicroPort EP MedTech Co., Ltd.

INDUSTRY